Lifecare ASA is a Norway-based company that develops miniaturized and implantable nanobiosensors for correct and continuous monitoring of glucose and other biomarkers. Lifecare's activities are concentrated on the development of sensor for use as a medical product, initially the sensor Sencell for continuous monitoring of glucose (blood sugar) for people with diabetes. The technology is suitable for detecting and measuring a wide range of molecules that can occur in the human body, based on variations in osmotic pressure.

Employees

Sector

Biotechnology & Medical Research

Calendar

11-12 Earnings release - Q3 2026

More about the company

Quotes

Date	Price	Change	Volume
22/09/26	NOK 0.3000	-2.76%	1,813,353
21/09/26	NOK 0.3085	-3.59%	771,360
18/09/26	NOK 0.3200	-4.48%	2,398,504
17/09/26	NOK 0.3350	+16.52%	6,798,341
16/09/26	NOK 0.2875	-0.17%	1,082,342

Real-time Oslo Bors

More quotes

EPS Estimates

Revisions to estimates

Annual profits - Rate of surprise

Company calendar

Market Closed - Oslo Bors 17:45:00 22/09/2026 +03			5-day change	1st Jan Change
0.3000 ^NOK	-2.76%		+4.17%	-90.80%

09-14	Lifecare Completes Acquisition of 87% Stake in Ocean TuniCell	MT
09-11	Lifecare ASA (OB:LIFE) acquired 86.7% stake in Ocean Tunicell AS from Captured AS.	CI

Market Cap	122M 12.94M 11.31M 10.63M 9.7M 18.2M 1.24B 18.21M 128M 49.22M 632M 48.6M 47.53M 2.04B	P/E 2026 *	-0.86x	P/E 2027 *	-1.88x
Enterprise Value	113M 11.99M 10.48M 9.85M 8.99M 16.86M 1.15B 16.87M 118M 45.6M 585M 45.02M 44.04M 1.89B	EV / Sales 2026 *	113x	EV / Sales 2027 *	-
Free-Float	71.12%	Yield 2026 *	-	Yield 2027 *	-

Markets		Quality
Oslo Bors	LIFE	Real-time
CBOE		Real-time
Nasdaq Stockholm	LIFE O	Delayed
Deutsche Boerse AG	LFC0	Delayed
Boerse Muenchen	LFC0	Real-time
Börse Stuttgart	LFC0	Delayed
CBOE		Real-time

09-14	Lifecare Completes Acquisition of 87% Stake in Ocean TuniCell	MT
09-11	Lifecare ASA (OB:LIFE) acquired 86.7% stake in Ocean Tunicell AS from Captured AS.	CI
08-31	Ocean GeoLoop Subsidiary to Sell Ocean Tunicell Stake to Lifecare	MT
08-19	Lifecare ASA Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
08-19	Lifecare ASA, Q2 2026 Earnings Call, Aug 19, 2026
07-02	Lifecare Completes Production Transfer and Provides Update on Longevity Programme	CI
06-29	Lifecare Transfers Operations from Germany to Norway, UK	MT
06-26	Lifecare ASA Discontinues Operations of Lifecare Germany GmbH	CI
06-19	An undisclosed buyer signed a non-binding agreement to acquire Ocean Tunicell AS from Ocean GeoLoop AS (OB:OCEAN).	CI
06-10	Lifecare Completes First Six-Month Implant Evaluation With Continued Functionality and No Adverse Biological Response	CI
05-15	Lifecare ASA, Q1 2026 Earnings Call, May 15, 2026
05-15	Lifecare ASA Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
05-15	Lifecare Q1 operating loss NOK 31.5 mln	RE

Lifecare ASA Stock

Stocks

LIFE

NO0013355859

Biotechnology & Medical Research

Valuation: Lifecare ASA

Chart: Lifecare ASA

Latest news: Lifecare ASA

Last Transcript: Lifecare ASA

Analysts' recommendations: Lifecare ASA

Press Releases: Lifecare ASA

News in other languages: Lifecare ASA

Quotes and Performance

Price Extremes

Managers and Directors: Lifecare ASA

Other Biotechnology & Medical Research

Financials

Company Profile

Quotes

Annual profits - Rate of surprise

08-19	Lifecare : Interim Report Q2 2026 Presentation	PU
08-19	LIFE: Lifecare ASA Q2 2026 results	PU
08-12	Lifecare ASA (LIFE): Invitation to presentation of Q2 2026 results 19 August at 08.45 CEST	AQ
07-02	LIFE: Update on production transfer and longevity programme	AQ
06-26	LIFE: Operational update regarding Lifecare Germany GmbH (i.L)	PU

1 day	-2.76%
1 week	+4.17%
Current month	+3.63%
1 month	+2.74%
3 months	-4.00%
6 months	-23.08%
Current year	-90.80%

1 week	0.28	0.34
1 month	0.28	0.34
Current year	0.27	1.99
1 year	0.27	11.25
3 years	0.27	82.16
5 years	0.27	82.16
10 years	0.27	117

Manager	Title	Age	Since
Joacim Holter CEO	Chief Executive Officer	50	07/09/2020
Petter Nielsen DFI	Director of Finance/CFO	-	01/04/2026
Torsten Ernst PRN	Corporate Officer/Principal	-	01/03/2024

Director	Title	Age	Since
Trine Teigland BRD	Director/Board Member	-	26/06/2020
Morten Foros Krohnstad CHM	Chairman	-	08/05/2021
Lutz Heinemann BRD	Director/Board Member	-	20/11/2020

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
LIFECARE ASA	-2.76%	+4.17%	-97.03%	-99.12%	13.33M
LONZA GROUP AG	+2.55%	+4.77%	+4.07%	+32.02%	46.68B
IQVIA HOLDINGS INC.	+0.08%	+0.16%	+43.79%	+35.89%	44.42B
BEONE MEDICINES AG	+0.66%	+6.23%	+8.96%	+93.14%	41.58B
REVOLUTION MEDICINES, INC.	+0.05%	-5.86%	+334.27%	+542.87%	41.32B
CELLTRION, INC.	-1.60%	+0.56%	+10.84%	+46.93%	30.14B
MEDPACE HOLDINGS, INC.	+0.96%	+1.56%	+26.52%	+159.67%	17.42B
ASCENDIS PHARMA A/S	-0.01%	-0.92%	-	-	15.6B
EUROFINS SCIENTIFIC SE	+1.15%	+7.46%	+25.97%	+43.93%	15.54B
TEMPUS AI, INC.	-1.08%	+12.11%	-10.11%	-	14.08B
Average	+0.03%	+2.39%	+38.59%	+106.91%	26.68B
Weighted average by Cap.	+0.48%	+0.96%	+69.14%	+144.52%

	2026 *	2027 *
Net sales	1M 106K 92.46K 86.9K 79.3K 149K 10.11M 149K 1.04M 402K 5.17M 397K 389K 16.65M	-
Net income	-109M -11.53M -10.08M -9.47M -8.64M -16.22M -1.1B -16.23M -114M -43.87M -563M -43.31M -42.36M -1.81B	-67M -7.09M -6.19M -5.82M -5.31M -9.97M -678M -9.97M -69.88M -26.96M -346M -26.62M -26.04M -1.12B
Net Debt	-9M -952K -832K -782K -714K -1.34M -91.03M -1.34M -9.39M -3.62M -46.49M -3.58M -3.5M -150M	4M 423K 370K 348K 317K 595K 40.46M 595K 4.17M 1.61M 20.66M 1.59M 1.55M 66.61M